期刊文献+

对氧磷酶3基因研究进展 被引量:6

Research Progress of Paraoxonase-3
下载PDF
导出
摘要 对氧磷酶3是对氧磷酶基因家族成员之一,除对氧磷酶3外,还包括对氧磷酶1和对氧磷酶2,它们具有大量结构同源性,且所有三个蛋白均能阻止氧化应激和对抗炎症,因此在许多疾病如动脉粥样硬化、肥胖、糖尿病、炎性肠病以及精神疾病中发挥重要作用。体外研究表明,对氧磷酶3的抗氧化能力比对氧磷酶1还要强,因此对氧磷酶3也可能具有成为某些疾病的治疗因子的潜能。本文总结近几年关于对氧磷酶3的一些最新发现,以便为对氧磷酶家族的进一步研究提供新思路。 Paraoxonase-3 (PON3) is a member of the paraoxonase (PON) family. In addition to PON3, it also includes PON1 and PON2. They share a large number of structural homology, and all the three proteins prevent oxidative stress and fight inflammation. They therefore seem central to a wide variety of human illnesses, including atherosclerosis, obesity, diabetes, inflammation bowel disorders and mental disorders. In vitro studies, the antioxidant capacity of PON3 is even stronger than PON1, so PON3 may also have the potential to become the treatment factors of certain diseases. The purpose of this review is to conclude some of the latest findings on PON3 in recent years, so as to provide new ideas for fur- ther research of the PON family.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2012年第10期945-950,共6页 Chinese Journal of Arteriosclerosis
关键词 对氧磷酶3 氧化应激 低密度脂蛋白 高密度脂蛋白 动脉粥样硬化 Paraoxonase-3 Oxidative Stress Low Density Lipoprotein High Density Lipoprotein Athero-sclerosis
  • 相关文献

参考文献32

  • 1Primo-Parmo SL, Sorenson RC, Teiber J, et al. The hu- man serum paraoxonase/arylesterase gene (PON) is one member of a multigene family [ J ]. Genomics, 1996, 33 : 498-507.
  • 2Reddy ST, Wadleigh DJ, Grijalva V, et al. Human parao- xonase-3 is an HDL-associated enzyme with biological ac- tivity similar to paraoxonase-1 protein but is not regulated by oxidized lipids [ J ]. Arterioscler Thromb Vasc Biol, 2001, 21 (4) : 542-547.
  • 3Ng C J, Wadleigh D J, Gangopadhyay A, et al. Paraoxo- nase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxida- tive modification of low density lipoprotein [ J ]. J Biol Chem, 2001, 276:44 444-449.
  • 4Costa LG, Cole TB, Vitalone A, et al. Measurement of paraoxonase ( PON1 ) status as a potential biomarker of sus- ceptibility to organophosphate toxicity [ J ]. Clin Chim Ac- ta, 2005, 352 (1-2): 37-47.
  • 5Draganov DI, Teiber JF, Speelman A, et al. Human para- oxonase (PON1, PON2, and PON3) are lactonase with o- verlapping and distinct substrate specificities [ J ]. J Lipid Res, 2005, 46:1 239-247.
  • 6Draganov DI, Stetson PL, Watson CE, et al. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associ- ated lactonase and protects low density lipoprotein against oxidation[J]. J Biol Chem, 2000, 275:33 435-442.
  • 7Aviram M, Billecke S, Sorenson R, et al. Paraoxonase ac- tive site required for protection against LDL oxidation in- volves its free sulfhydryl group and is different from that re- quired for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R[ J]. Arte- rioscler Thromb Vasc Biol, 1998. 18 : 1 617-624.
  • 8Campo S, Sardo AM, Campo GM, et al. Identification of paraoxonase 3 gene (PON3) missense mutations in a popu- lation of southern Italy[J]. Murat Res, 2004, 546 (1-2) : 75-80.
  • 9Sanghera DK, Manzi S, Minster RL, et al. Genetic varia- tion in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity[J]. Genet, 2008, 72 (1): 72-81.
  • 10Labrecque B, Beaudry D, Mayhue M, et al. Molecular characterization and expression analysis of the porcine paraoxonase 3 ( PON3 ) gene [ J ]. Gene, 2009, 443 ( 1- 2) : 110-120.

二级参考文献17

  • 1伍海涛,熊小明,王双喜,吴晋湘,刘立英.银杏叶提取物对高脂饮食所致血管内皮功能损伤的保护及与对氧磷酶活性的关系[J].中国动脉硬化杂志,2004,12(4):410-414. 被引量:12
  • 2Chambers .IE. PONI muhitasks to protect health [.I]. Proc Natl Acad Sci USA, 2008, 105 (35) : 12 639-640.
  • 3Mackness B, Durrington P, McEtduff P, et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study [ J]. Circulation, 2003, 107 (22) : 2 775 -779.
  • 4Costa LG, Cole TB, Furlong CE. Paraoxonase ( PON 1 ) : from toxicology to cardiovascular medicine [ J ]. ACTA BIOMED, 2005, 76 (Suppl 2 ) : 50- 57.
  • 5van Himbergen TM, van Tits LJH. Roest M, et al. The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine [ J ]. Neth J Med, 2006 , 64 (2) : 34-38.
  • 6Arao T, Fuke C, Takaesu H, et al. A case of fatal trichlorfon and methidathion poisoning [J]. Legal Medicine, 2002, 4(3) : 182-186.
  • 7Thomas S, Kotamraju S, Zielonka J, et al. Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response[J]. Free Radic Bill Med, 2007, 42(7) : 1 049-061.
  • 8Mackness MI, Mackness B, Durrington PN. Paraoxonase and coronary heart disease [J]. Atheroscler, 2002, Suppl 3 (4) : 49-55.
  • 9Simon BC, Cunningham LD, Cohen RA, et al. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery [ J ]. J Clin Invest, 1990, 86 ( 1 ) : 75-79.
  • 10Furlong CE. PONI status and neumlogic symptom complexes in Gurf war veterans [J]. Genome Res, 2000, 10 (2) : 153-155.

共引文献5

同被引文献66

  • 1徐运.氧化应激与脑缺血再灌注损伤[J].中国卒中杂志,2008,3(3):195-197. 被引量:16
  • 2范义 ,滕妍 ,张启周 ,胡卫东 ,娄明武 .人硫氧还蛋白对脑缺血作用的CT灌注与SOD相关性的实验研究[J].北华大学学报(自然科学版),2005,6(4):306-310. 被引量:6
  • 3Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis [ J ]. Hypertension, 2005,45 ( 6 ) : 1042 - 1049.
  • 4Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reperfu- sion injury [ J ]. Ann NY Acad Sci,2005,1047 (6) :248 - 258.
  • 5Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and car- diovascular disease [ J ]. Atherosclerosis, 2009,202 ( 2 ) : 321 - 329.
  • 6Cherubini A, Ruggiero C, Polidori MC, et al. Potential markers of oxi- dative stress in stroke [ J ]. Free Radic Biol Med,2005,39 (7) : 841 - 852.
  • 7Stocker R, Keaney JF Jr. Role of oxidative modification in atheroscle- rosis[J]. Phsiol Rev,2004,84(4) :1381 - 1478.
  • 8Fang R, Zhang N, Wang C,et al. Relations between plasma ox -LDL and carotid plaque among Chinese Han ethnic group [ J]. Neurol Res,2011,33 (5) :460 -466.
  • 9Holvoet P, Kritchevsky SB, Tracy RP, et al. The meatabolic syn- drome, circulating oxidized LDL and risk of myocardia infarction in well-functioning elderly people in the health, aging, and body compo- sition cohort [ J ]. Diabetes,2004,53 ( 4 ) : 1068 - 1071.
  • 10Holvoet P, Lee DH, Steffes M, et al. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syn- drome[ J ]. JAMA,2008,299 (19) :2287 - 2293.

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部